We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-c... Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.059 | -14.0476190476 | 0.42 | 0.42 | 0.29 | 207241 | 0.37484609 | CS |
4 | -0.319 | -46.9117647059 | 0.68 | 0.68 | 0.29 | 121341 | 0.43165467 | CS |
12 | -0.486 | -57.3789846517 | 0.847 | 0.899 | 0.29 | 94978 | 0.62729561 | CS |
26 | -0.739 | -67.1818181818 | 1.1 | 1.39 | 0.29 | 96314 | 0.81165332 | CS |
52 | -4.459 | -92.510373444 | 4.82 | 5 | 0.29 | 82557 | 1.24857968 | CS |
156 | -16.889 | -97.9072463768 | 17.25 | 19.35 | 0.29 | 241042 | 7.98197627 | CS |
260 | -61.739 | -99.4186795491 | 62.1 | 158.1 | 0.29 | 438053 | 42.37228513 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions